ARTICLE
14 July 2022

Holland & Knight Health Dose: July 12, 2022

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences
Holland & Knight are most popular:
  • within Strategy topic(s)

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Congress This Week: A Packed Summer Agenda
  • Biden Administration to Extend the Public Health Emergency (PHE)
  • CMS Releases CY 2023 Medicare Physician Fee Schedule (MPFS) Proposed Rule
  • PRF Reporting Period 3 Portal Opens
  • National Stakeholder Call on July 19 with the CMS Administrator
  • New CMS Report Reveals Implicit Bias in Value-Based Models
  • Payer Price Transparency Requirements in Effect as of July 1
  • FDA Seeks to Expand Accelerated Approval Pathway to New Uses
  • CMS Soliciting Feedback on Social Risk Factor Readmissions Measures
  • 2023 Rate Hikes Expected Next Year, Though Impact Depends on Congressional Action
  • COVID-19 Update

Read the full Health Dose »

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More